The act of building an AI model is often depicted as the difficult part.
In practice, data integration can be just as hard, especially in the pharma context.
A typical pharma operation has multiple sources:
RFID ───────┐
BLE ────────┤
Sensors ────┤
Equipment ──┼──> Edge / Integration Layer ──> Analytics / AI
MES ────────┤
ERP ────────┤
LIMS ───────┤
QMS ────────┘
Each source has a different purpose, and potentially different data structures.
An RFID system may answer:
Where is the asset?
A manufacturing system may answer:
What production stage is active?
An ERP system may answer:
What inventory is available?
A lab system may answer:
What testing information is associated with the material?
Each individually is helpful. Combined, they can be much more powerful.
Context Changes the Value of Data
If an asset's position changes, that alone is informative.
However, if the system can associate that movement with a production activity, equipment state, inventory requirement or maintenance event, the operational value becomes much richer.
This is one reason AIoT architectures are interesting.
The IoT layer provides physical world data.
The integration layer connects these various sources.
The AI layer can then analyze the relationships and patterns in that information.
Why Edge Computing Matters
Industrial environments can also benefit from processing information closer to where it is generated.
Edge architectures can help reduce unnecessary data movement, support local processing and provide a bridge between physical devices and enterprise applications.
The exact architecture will vary depending on the operational requirements, but the principle is consistent:
AI cannot be separated from the quality and context of the data feeding into it.
For pharma manufacturers, this is particularly important because operational information may span equipment, materials, people, production, environmental variables and quality processes.
Platforms such as PharmaFlux AI approach the problem by bringing AI, IoT, RFID, BLE, edge technologies and pharma systems into a connected manufacturing environment.
The interesting engineering challenge isn't simply “How do we add AI?”
It's:
How do we build an architecture where AI can understand the physical operation?
That is where industrial AI becomes much more than a chatbot or prediction model.
Top comments (0)